IV
InVitro International
IVRO · OTC
$0.06 +0.00% (+$0.00)
1M -18.92%
Market Cap $1.34M
P/E Ratio 21.18x
Div. Yield -
ROE 3.76%
Bulios Fair Price
$0.06
0.0% downside
Current Price
$0.06
Undervalued Fair Value Overvalued
According to Bulios Fair Price, IVRO is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
85 /100
Cheap P/E 21.18x
PEG 0.76x
EV/EBITDA 6.57x
Growth
58 /100
Stable EPS growth 80.58%
Book val. growth 4.70%
Rev. growth 0.98%
Profitability
39 /100
Moderate Gross margin 81.88%
FCF margin 0.01%
Net margin 8.18%
Quality
16 /100
Poor ROIC 1.70%
Asset turnover 0.39x
ROE 3.76%
Debt
100 /100
Low Debt/Equity 0.14x
Net debt/EBITDA -18.49x
Current ratio 11.56x
Stability
58 /100
Moderate Beta -0.83x
Profitable years 6
Rev. volatility 7.80%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about IVRO
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
W. Richard Ulmer
Employees
5
Headquarters
Placentia